Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
Cancer, 09/06/2011
Kim JJ et al. – In metastatic clear cell renal cell carcinoma (MCCRCC) patients treated with sunitinib, vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs)-634 is associated with hypertension and a combination of VEGF SNP 936 and VEGFR2 SNP 889 genotypes is associated with overall survival.







